Cargando…

MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206

Terminal differentiation of distinct cell types requires the transcriptional activation of differentiation-specific genes and the suppression of genes associated with the precursor cell. For example, the expression of utrophin (Utrn) is suppressed during skeletal muscle differentiation, and it is re...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, Miriam I., Georges, Sara A., Asawachaicharn, Amy, Analau, Erwin, Tapscott, Stephen J.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2064500/
https://www.ncbi.nlm.nih.gov/pubmed/17030984
http://dx.doi.org/10.1083/jcb.200603039
_version_ 1782137552423092224
author Rosenberg, Miriam I.
Georges, Sara A.
Asawachaicharn, Amy
Analau, Erwin
Tapscott, Stephen J.
author_facet Rosenberg, Miriam I.
Georges, Sara A.
Asawachaicharn, Amy
Analau, Erwin
Tapscott, Stephen J.
author_sort Rosenberg, Miriam I.
collection PubMed
description Terminal differentiation of distinct cell types requires the transcriptional activation of differentiation-specific genes and the suppression of genes associated with the precursor cell. For example, the expression of utrophin (Utrn) is suppressed during skeletal muscle differentiation, and it is replaced at the sarcolemma by the related dystrophin protein. The MyoD transcription factor directly activates the expression of a large number of skeletal muscle genes, but also suppresses the expression of many genes. To characterize a mechanism of MyoD-mediated suppression of gene expression, we investigated two genes that are suppressed in fibroblasts converted to skeletal muscle by MyoD, follistatin-like 1 (Fstl1) and Utrn. MyoD directly activates the expression of a muscle-specific microRNA (miRNA), miR-206, which targets sequences in the Fstl1 and Utrn RNA, and these sequences are sufficient to suppress gene expression in the presence of miR-206. These findings demonstrate that MyoD, in addition to activating muscle-specific genes, induces miRNAs that repress gene expression during skeletal muscle differentiation.
format Text
id pubmed-2064500
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-20645002007-11-29 MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206 Rosenberg, Miriam I. Georges, Sara A. Asawachaicharn, Amy Analau, Erwin Tapscott, Stephen J. J Cell Biol Research Articles Terminal differentiation of distinct cell types requires the transcriptional activation of differentiation-specific genes and the suppression of genes associated with the precursor cell. For example, the expression of utrophin (Utrn) is suppressed during skeletal muscle differentiation, and it is replaced at the sarcolemma by the related dystrophin protein. The MyoD transcription factor directly activates the expression of a large number of skeletal muscle genes, but also suppresses the expression of many genes. To characterize a mechanism of MyoD-mediated suppression of gene expression, we investigated two genes that are suppressed in fibroblasts converted to skeletal muscle by MyoD, follistatin-like 1 (Fstl1) and Utrn. MyoD directly activates the expression of a muscle-specific microRNA (miRNA), miR-206, which targets sequences in the Fstl1 and Utrn RNA, and these sequences are sufficient to suppress gene expression in the presence of miR-206. These findings demonstrate that MyoD, in addition to activating muscle-specific genes, induces miRNAs that repress gene expression during skeletal muscle differentiation. The Rockefeller University Press 2006-10-09 /pmc/articles/PMC2064500/ /pubmed/17030984 http://dx.doi.org/10.1083/jcb.200603039 Text en Copyright © 2006, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Research Articles
Rosenberg, Miriam I.
Georges, Sara A.
Asawachaicharn, Amy
Analau, Erwin
Tapscott, Stephen J.
MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206
title MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206
title_full MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206
title_fullStr MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206
title_full_unstemmed MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206
title_short MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206
title_sort myod inhibits fstl1 and utrn expression by inducing transcription of mir-206
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2064500/
https://www.ncbi.nlm.nih.gov/pubmed/17030984
http://dx.doi.org/10.1083/jcb.200603039
work_keys_str_mv AT rosenbergmiriami myodinhibitsfstl1andutrnexpressionbyinducingtranscriptionofmir206
AT georgessaraa myodinhibitsfstl1andutrnexpressionbyinducingtranscriptionofmir206
AT asawachaicharnamy myodinhibitsfstl1andutrnexpressionbyinducingtranscriptionofmir206
AT analauerwin myodinhibitsfstl1andutrnexpressionbyinducingtranscriptionofmir206
AT tapscottstephenj myodinhibitsfstl1andutrnexpressionbyinducingtranscriptionofmir206